Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Cerenome to Hold CNSide® Business Update Call on September 30, 2026

$CNSYPress releaseSep 25, 2026, 7:30 AM ETRead the release

Cerenome (Nasdaq: CNSY) announced a business update call for Wednesday, September 30, 2026, at 8:30 a.m. ET covering its CNSide CSF diagnostic platform. The update will focus on recent commercial developments including third-party billing, market access, expansion of the commercial team, and broadening of the diagnostic testing portfolio.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.